Evolving Pharmacologic Intervention for Methamphetamine Use Disorder: A Focus on ADAPT-2 - a podcast by ReachMD

CME credits: 0.25

Valid until: 30-09-2022

Claim your CME credit at https://reachmd.com/programs/cme/evolving-pharmacologic-intervention-for-methamphetamine-use-disorder-a-focus-on-adapt-2/12907/

Join Drs. Madhukar Trivedi and Steven Shoptaw as they discuss the evolving landscape of pharmacologic intervention for methamphetamine use disorder. Their focus will be on evidence from the ADAPT-2 clinical trial supporting the combination of extended release naltrexone and high dose bupropion to reduce methamphetamine use for patients with moderate to severe methamphetamine addiction. These important data from ADAPT-2 offer a significant therapeutic advance for methamphetamine use disorder that can be taken into the clinic.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD